Given the broad and substantial effects of NIK inhibition on multiple pro-inflammatory endpoints, we next conducted a survival study in IFNα-accelerated NZB/W F1 lupus prone mice. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.